Terms: = Prostate cancer AND CCND3, P30281, 896, ENSG00000112576
102 results:
1. SGLT2 inhibition and three urological cancers: Up-to-date results.
Lin L; Ning K; Xiang L; Peng L; Li X
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3797. PubMed ID: 38523292
[TBL] [Abstract] [Full Text] [Related]
2. Highly accurate and effective deep neural networks in pathological diagnosis of prostate cancer.
Zhang C; Gao X; Fan B; Guo S; Lyu X; Shi J; Fu Y; Zhang Q; Liu P; Guo H
World J Urol; 2024 Feb; 42(1):93. PubMed ID: 38386116
[TBL] [Abstract] [Full Text] [Related]
3. Non-Invasive Diagnosis of prostate cancer and High-Grade prostate cancer Using Multiparametric Ultrasonography and Serological Examination.
Li J; Zhu C; Yang S; Mao Z; Lin S; Huang H; Xu S
Ultrasound Med Biol; 2024 Apr; 50(4):600-609. PubMed ID: 38238199
[TBL] [Abstract] [Full Text] [Related]
4. Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy.
Blas L; Shiota M; Tanegashima T; Tsukahara S; Ueda S; Mutaguchi J; Goto S; Kobayashi S; Matsumoto T; Inokuchi J; Eto M
Int J Urol; 2024 Apr; 31(4):404-408. PubMed ID: 38154806
[TBL] [Abstract] [Full Text] [Related]
5. Meta-analysis of
Yu W; Zhao M; Deng Y; Liu S; Du G; Yan B; Zhao Z; Sun N; Guo J
Cancer Imaging; 2023 Aug; 23(1):77. PubMed ID: 37605288
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic Performance and Safety of Positron Emission Tomography with
Surasi DS; Eiber M; Maurer T; Preston MA; Helfand BT; Josephson D; Tewari AK; Somford DM; Rais-Bahrami S; Koontz BF; Bostrom PJ; Chau A; Davis P; Schuster DM; Chapin BF;
Eur Urol; 2023 Oct; 84(4):361-370. PubMed ID: 37414702
[TBL] [Abstract] [Full Text] [Related]
7. Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis.
Sato G; Shirai Y; Namba S; Edahiro R; Sonehara K; Hata T; Uemura M; ; Matsuda K; Doki Y; Eguchi H; Okada Y
Nat Commun; 2023 Jun; 14(1):3671. PubMed ID: 37340002
[TBL] [Abstract] [Full Text] [Related]
8. Risk-based screening for second primary extrapulmonary malignancies in stage I lung cancer patients: A study based on SEER database.
Wang T; Zhou J; Zheng Q; Wu D; Lu T; Lin M; Pu Q; Mei J; Liu L
Lung Cancer; 2023 Jun; 180():107218. PubMed ID: 37146472
[TBL] [Abstract] [Full Text] [Related]
9. Changes in Urologic cancer Surgical Volume and Length of Stay During the COVID-19 Pandemic in Pennsylvania.
Chun B; Ramian H; Jones C; Vasan R; Yabes JG; Davies BJ; Sabik LM; Jacobs BL
JAMA Netw Open; 2023 Apr; 6(4):e239848. PubMed ID: 37097635
[TBL] [Abstract] [Full Text] [Related]
10. Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database.
Kim JK; Jung G; Kwak C; Jeong CW; Kang SH; Hong SH; Kim YJ; Chung J; Hwang EC; Kwon TG; Byun SS
PLoS One; 2023; 18(3):e0283483. PubMed ID: 36996119
[TBL] [Abstract] [Full Text] [Related]
11. Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men.
Siddiqui MR; Li EV; Kumar SKSR; Busza A; Lin JS; Mahenthiran AK; Aguiar JA; Shah PV; Ansbro B; Rich JM; Moataz SAS; Keeter MK; Mai Q; Mi X; Tosoian JJ; Schaeffer EM; Patel HD; Ross AE
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):588-595. PubMed ID: 36973367
[TBL] [Abstract] [Full Text] [Related]
12. Prediction of adaptive strategies based on deformation vector field features for MR-guided adaptive radiotherapy of prostate cancer.
Xia WL; Liang B; Men K; Zhang K; Tian Y; Li MH; Lu NN; Li YX; Dai JR
Med Phys; 2023 Jun; 50(6):3573-3583. PubMed ID: 36583878
[TBL] [Abstract] [Full Text] [Related]
13. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
14. A single-centre, open-label, single-arm, fixed-sequence pharmacokinetic study of SHR3680 on repaglinide and bupropion in prostate cancer patients.
Dai T; Xu Z; Huang L; Wang Y; Zeng G; Ye M; Liu K; Zeng F; Jiang S; Han W; Cao J
Br J Clin Pharmacol; 2023 Feb; 89(2):874-886. PubMed ID: 36098470
[TBL] [Abstract] [Full Text] [Related]
15. Development and external validation of a novel nomogram to predict prostate cancer in biopsy-naïve patients with PSA <10 ng/ml and PI-RADS v2.1 = 3 lesions.
Hu C; Sun J; Xu Z; Zhang Z; Zhou Q; Xu J; Chen H; Wang C; Ouyang J
Cancer Med; 2023 Feb; 12(3):2560-2571. PubMed ID: 35920264
[TBL] [Abstract] [Full Text] [Related]
16. Metformin for Prevention of Anthropometric and Metabolic Complications of Androgen Deprivation Therapy in prostate cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled Trial.
Usmani N; Ghosh S; Sanghera KP; Ong AD; Koul R; Dubey A; Ahmed S; Quon H; Yee D; Parliament M; Sivananthan G; Hunter W; Danielson B; Rowe L; McDonald M; Kim JO
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):317-326. PubMed ID: 35907513
[TBL] [Abstract] [Full Text] [Related]
17. Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan.
Shiota M; De Moor R; Koroki Y; Yu DY; Wu DB
Curr Med Res Opin; 2022 Aug; 38(8):1351-1359. PubMed ID: 35770513
[TBL] [Abstract] [Full Text] [Related]
18. prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives.
Zheng G; Sundquist J; Sundquist K; Ji J
Cancer Med; 2022 May; 11(10):2117-2124. PubMed ID: 35312170
[TBL] [Abstract] [Full Text] [Related]
19. cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic prostate cancer: A Multi-institute 15-year Experience.
Reddy D; Peters M; Shah TT; van Son M; Tanaka MB; Huber PM; Lomas D; Rakauskas A; Miah S; Eldred-Evans D; Guillaumier S; Hosking-Jervis F; Engle R; Dudderidge T; Hindley RG; Emara A; Nigam R; McCartan N; Valerio M; Afzal N; Lewi H; Orczyk C; Ogden C; Shergill I; Persad R; Virdi J; Moore CM; Arya M; Winkler M; Emberton M; Ahmed HU
Eur Urol; 2022 Apr; 81(4):407-413. PubMed ID: 35123819
[TBL] [Abstract] [Full Text] [Related]
20. Long-Term Risk of Clinical Progression Utilizing Magnetic Resonance Imaging Findings of Locally Recurrent prostate cancer in Patients with Biochemical Recurrence following Radical prostatectomy.
Tanaka T; Kawashima A; Rangel LJ; Schulte PJ; Froemming AT; King BF; Mynderse LA; Karnes RJ
J Urol; 2022 May; 207(5):1038-1047. PubMed ID: 34981952
[TBL] [Abstract] [Full Text] [Related]
[Next]
